Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$100.57 - $116.37 $156,889 - $181,537
1,560 Added 59.45%
4,184 $466,000
Q2 2024

Jul 18, 2024

SELL
$103.94 - $118.98 $162,146 - $185,608
-1,560 Reduced 37.28%
2,624 $280,000
Q1 2024

Apr 15, 2024

SELL
$115.19 - $132.77 $33,865 - $39,034
-294 Reduced 6.57%
4,184 $503,000
Q4 2023

Jan 11, 2024

BUY
$114.26 - $136.0 $511,656 - $609,008
4,478 New
4,478 $550,000
Q2 2023

Jul 14, 2023

SELL
$122.5 - $147.16 $82,932 - $99,627
-677 Reduced 12.87%
4,585 $568,000
Q1 2023

Apr 12, 2023

BUY
$133.98 - $160.47 $705,002 - $844,393
5,262 New
5,262 $769,000
Q2 2022

Jul 12, 2022

SELL
$141.59 - $168.66 $16,849 - $20,070
-119 Reduced 2.21%
5,262 $821,000
Q1 2022

Apr 14, 2022

SELL
$129.64 - $160.7 $12,445 - $15,427
-96 Reduced 1.75%
5,381 $838,000
Q4 2021

Jan 21, 2022

SELL
$119.87 - $145.67 $108,961 - $132,414
-909 Reduced 14.23%
5,477 $718,000
Q3 2021

Oct 25, 2021

SELL
$128.64 - $184.79 $9,647 - $13,859
-75 Reduced 1.16%
6,386 $831,000
Q2 2021

Jul 21, 2021

SELL
$160.2 - $186.42 $56,069 - $65,246
-350 Reduced 5.14%
6,461 $1.15 Million
Q1 2021

May 17, 2021

SELL
$150.19 - $173.5 $401,007 - $463,245
-2,670 Reduced 28.16%
6,811 $1.12 Million
Q4 2020

Feb 10, 2021

SELL
$140.71 - $165.05 $11,538 - $13,534
-82 Reduced 0.86%
9,481 $1.57 Million
Q3 2020

Nov 10, 2020

SELL
$105.46 - $144.13 $206,174 - $281,774
-1,955 Reduced 16.97%
9,563 $1.36 Million
Q2 2020

Aug 14, 2020

SELL
$95.68 - $121.88 $255,944 - $326,029
-2,675 Reduced 18.85%
11,518 $1.27 Million
Q1 2020

May 12, 2020

BUY
$87.74 - $152.74 $1.25 Million - $2.17 Million
14,193 New
14,193 $1.42 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Cfm Wealth Partners LLC Portfolio

Follow Cfm Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cfm Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cfm Wealth Partners LLC with notifications on news.